Biomedical advances
3D-printed medicines and personalised pharmacy
For over a century, medicines have been mass-produced in factories as identical tablets and capsules. Now a new idea is taking shape: printing medicines to order, tailored to the individual. 3D-printed medicines use the same layer-by-layer building principle as other 3D printing, but with medicine ingredients instead of plastic. The promise is pills matched to a person's exact needs — the right dose, several medicines combined, or a tablet designed to dissolve in a particular way. This guide explains how the technology works, what it could offer patients, and where it stands in terms of evidence and regulation.
Education and reference only. This article explains how treatments work in plain language — it contains no doses and is not a substitute for advice from your doctor or pharmacist. Always discuss your own treatment with a qualified clinician.
How printing a pill works
3D printing builds an object by adding material in thin layers, following a digital design. Applied to medicines, this means constructing a tablet layer by layer from a mixture containing the active drug and other ingredients that hold it together and control how it dissolves. Several approaches exist: some squeeze out a paste that sets into shape, some fuse powder together, and some build with light-sensitive materials. Because the design is digital, the size, shape, internal structure and dose can be adjusted simply by changing the file. This is very different from traditional manufacturing, where changing a tablet's design means retooling an entire production line and making millions of identical units.
Tailored doses and combinations
The most obvious benefit is personalisation. Standard medicines come in a limited range of strengths, so getting the exact dose a person needs can mean splitting tablets or taking awkward combinations. This is especially difficult for children, older people and those whose dose depends closely on body weight, kidney function or blood test results. 3D printing could produce a tablet at precisely the right strength for one individual. It could also combine several medicines into a single pill — a so-called polypill — which is appealing for people who otherwise take many tablets a day. Fewer, better-matched pills could make treatment simpler and help people take their medicines correctly.
Designing how a medicine behaves
Beyond dose, printing gives fine control over how a medicine is released in the body. By changing a tablet's internal structure — how solid or porous it is, or arranging different materials in layers — a printed pill can be designed to dissolve quickly, slowly, or in stages. A single tablet could release one drug immediately and another over several hours. Printing can also create tablets that are easier to swallow, or that dissolve on the tongue for people who struggle with normal pills. Some research explores printing shapes and even flavours that appeal to children. This flexibility to design not just what is in a pill but how and when it works is a key attraction of the technology.
Where the technology stands
3D-printed medicines are a real and active field, not just an idea. A 3D-printed tablet has already been approved and marketed in some countries, showing the concept can work at scale for the right product. Much research is happening in universities and hospital pharmacies, exploring printing at the point of care — for example, in a hospital pharmacy producing tailored doses for individual patients. But important challenges remain: proving that each printed tablet is consistent and contains exactly the intended dose, ensuring the printers and materials are reliable, and fitting on-demand printing into the tightly controlled world of pharmacy. The vision of a printer in every pharmacy is not here yet, but the building blocks are being put in place.
Safety, regulation and the future
Medicines are strictly regulated to guarantee they are safe, effective and made to a consistent quality, and 3D-printed medicines must meet the same high standards. In the UK, medicines are overseen by the medicines regulator, and printing pills closer to the patient raises new questions: who is responsible for quality, how is each batch checked, and how are printers and ingredients controlled? These are being actively worked through. If the challenges are solved, the potential is significant — medicines tailored to children, to rare conditions, or to people on many drugs, printed on demand and adjusted as their needs change. It is an example of medicine moving from one-size-fits-all towards treatment designed around the individual.
In short
Key takeaways
- 3D-printed medicines build tablets layer by layer from a digital design, allowing size, dose and structure to be tailored.
- The technology could produce exact individual doses and combine several medicines into a single pill.
- Printing gives fine control over how and when a medicine is released in the body.
- A 3D-printed tablet has already been approved in some countries, and hospital and university research is active.
- Printed medicines must meet the same strict safety and quality standards as all medicines, and UK regulation is evolving to match.
Answers
Frequently asked questions
Are 3D-printed medicines available on the NHS now?
Not as everyday, on-demand printed pills. The technology is real and advancing — a 3D-printed tablet has been approved and sold in some countries, and research is happening in UK universities and hospital pharmacies. But routine printing of tailored medicines in your local pharmacy is not yet standard practice. Important questions about quality checking, safety and regulation are still being worked through before this could become widespread. It represents a promising direction rather than something you can currently ask for.
Would a printed pill be as safe as a normal one?
It would have to be. All medicines in the UK must meet strict standards for safety, effectiveness and consistent quality before they can be used, and 3D-printed medicines are held to the same rules. In fact, a major focus of research is proving that every printed tablet contains exactly the intended dose and behaves reliably. Printing medicines closer to patients raises new questions about who checks quality and how, and these must be answered before printed pills become part of routine care.
Why would printing medicines be better than mass production?
Mass production is efficient but makes identical tablets in a limited range of strengths, so getting the exact dose an individual needs can mean splitting pills or juggling several medicines. Printing allows a tablet to be made at precisely the right dose for one person, to combine several drugs into one pill, and to be designed to release medicine in a particular way. This could be especially helpful for children, older people, and those on many medicines, moving treatment towards being tailored to the individual.
Sources
Where this is drawn from
- Medicines and Healthcare products Regulatory Agency (MHRA). Innovative manufacturing and point-of-care medicines: guidance. 2023.
- Royal Pharmaceutical Society. Emerging technologies in pharmacy: 3D printing of medicines. 2023.
- European Medicines Agency (EMA). Reflection on additive manufacturing of medicinal products. 2023.
Need clear, evidence-led health content?
We write accurate, dose-free patient information and medicines content for teams.